August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
A New Treatment Option for Advanced EGFR-Mutant NSCLC – IASLC
Jul 20, 2025, 19:20

A New Treatment Option for Advanced EGFR-Mutant NSCLC – IASLC

International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:

“A new treatment option has entered the landscape for patients with advanced EGFR-mutant NSCLC.

In the latest Lung Cancer Considered, Dr. Narjust Florez sits down with Dr. Jacob Sands to review the FDA approval of datopotamab deruxtecan for patients who have progressed on both EGFR-targeted therapy and platinum-based chemotherapy.

The conversation highlights trial data, patient selection, and what this new approval means for clinical practice.

Listen now.”

More posts featuring IASLC.